基于代谢组学和高通量测序技术筛选中药制剂“连栀矾溶液”发酵过程中的关键真菌菌株

Screening of Key Fungal Strains in the Fermentation Process of the Chinese Medicinal Preparation "Lianzhifan Solution" Based on Metabolic Profiling and High-Throughput Sequencing Technology.

作者信息

Xie Jie, Ye Yang, Wu Ze, Gou Xun, Peng Tong, Yuan Xuegang, Yang Xiangdong, Zhang Xiaoyu, Peng Quekun

机构信息

College of Life Sciences, Sichuan Normal University, Chengdu, China.

Keystonecare Technology (Chengdu) Co., Ltd., Chengdu, China.

出版信息

Front Microbiol. 2021 Aug 23;12:727968. doi: 10.3389/fmicb.2021.727968. eCollection 2021.

Abstract

"Lianzhifan solution" (LZF) is produced by the natural fermentation of coptis root and gardenia fruit, and it is a classic prescription for external use in anorectal department. During the fermentation process, the structural evolution of microbial communities led to significant changes in the chemical profile. In this study, we first analyzed the dynamic changes of chemical components as well as the composition and succession of microbial community during the whole fermentation process of LZF, and confirmed the changes of characteristics of nine compounds during the whole fermentation process by metabolic profile. Further analysis found that there was no significant change of alkaloids in all stages of fermentation of LZF, but there were significant changes of iridoids in the middle and late stage of fermentation by deglycosylation. Genipin gentiobioside and geniposide were converted to genipin by biotransformation, showing that deglycosylation was the main event occurring in the fermentation. The community composition and abundance of species in 10 and 19days LZF fermentation broth were analyzed with high-throughput sequencing technology, and 16 dominant bacterial genera and 15 dominant fungal genera involved in the fermentation process were identified. Correlation analysis revealed that and involved in the fermentation were the dominant genera closely related to the dynamic changes of the deglycosylation of the main chemical components, and YY-46 and YY-9 strains were obtained by the further fractionation. Then the monoculture fermentation process was evaluated, whereby we found that the deglycoside conversion rate of iridoid glycosides was greatly improved and the fermentation cycle was shortened by 3-4 times. This finding combined with equivalence evaluation of chemical component and pharmacodynamics to confirm that YY-46 and YY-9 strains were key strains for fermentation concoction. This study established an efficient and practical screening strategy "Microfauna communities-Chemical component-Pharmacodynamic" axis for key strain, to improve the production process and formulating good manufacturing practice (GMP) work, and it is also applicable to the whole fermentation drugs industry. Graphical AbstractThe figure highly summarizes the research content of this study and shows the screening process of key strains in LZF fermentation.

摘要

“连栀矾溶液”(LZF)由黄连和栀子天然发酵制成,是肛肠科外用经典方剂。在发酵过程中,微生物群落的结构演变导致化学图谱发生显著变化。本研究首先分析了LZF整个发酵过程中化学成分的动态变化以及微生物群落的组成和演替,并通过代谢谱确认了整个发酵过程中9种化合物特征的变化。进一步分析发现,LZF发酵各阶段生物碱无显著变化,但发酵中后期环烯醚萜类通过去糖基化发生显著变化。栀子苷元龙胆双糖苷和栀子苷通过生物转化转化为栀子苷元,表明去糖基化是发酵过程中的主要事件。采用高通量测序技术分析了LZF发酵10天和19天的发酵液中群落组成和物种丰度,鉴定出参与发酵过程的16个优势细菌属和15个优势真菌属。相关性分析表明,参与发酵的 和 是与主要化学成分去糖基化动态变化密切相关的优势属,并通过进一步分馏获得了YY-46和YY-9菌株。然后对单培养发酵过程进行评估,发现环烯醚萜苷的去糖苷转化率大大提高,发酵周期缩短了3-4倍。这一发现结合化学成分和药效学的等效性评价,确认YY-46和YY-9菌株是发酵炮制的关键菌株。本研究建立了一种高效实用的关键菌株筛选策略“微生物群落-化学成分-药效学”轴,以改进生产工艺并形成良好生产规范(GMP)工作,也适用于整个发酵药物行业。图形摘要该图高度概括了本研究的研究内容,并展示了LZF发酵中关键菌株的筛选过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f64/8420715/955af5e430ae/fmicb-12-727968-g010.jpg

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索